The chemokine growth-regulated oncogene 1 (Gro-1) links RAS signaling to the senescence of stromal fibroblasts and ovarian tumorigenesis
Open accessThe DOI matches its Crossref record; 48 of the 49 references it cites were found in a registry or an index.
Abstract
Epithelial–stromal interactions play a critical role in tumor initiation and progression; cancer-associated stroma, but not normal stroma, is known to be tumor-promoting. However, the molecular signal used by epithelial cancer cells to reprogram normal stroma to a tumorigenic stroma is not known. Here, we present evidence to suggest that the chemokine growth-regulated oncogene 1 (Gro-1) may be one such signaling molecule. We showed that the expression of Gro-1 is activated by RAS and is vital for cell survival and the malignant transformation of ovarian epithelial cells. Surprisingly, we found that Gro-1 is a potent inducer of senescence in stromal fibroblasts and that this effect depends on functional p53. Senescent fibroblasts induced by Gro-1 can promote tumor growth whereas abrogation of senescence through immortalization results in loss of such tumor promoting activity. We also demonstrated that stromal fibroblasts adjacent to epithelial cancer cells are senescent in human ovarian cancer specimens and in heterografts from RAS-transformed human ovarian epithelial cells and ovarian cancer cells. Moreover, Gro-1 was expressed at significantly higher amounts in ovarian cancer than in normal tissues and was higher in serum samples from women with ovarian cancer than in serum from women without ovarian cancer. These findings provide strong evidence that RAS-induced Gro-1 can reprogram the stromal microenvironment through the induction of senescence of fibroblasts and thus can promote tumorigenesis. Therefore, Gro-1 may be a therapeutic target as well as a diagnostic marker in ovarian cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Other SASP factors implicated in stimulating tumor cell growth are amphiregulin and the GROs (94–96), but there are a plethora of other candidates.”
From Aging, Cellular Senescence, and Cancer (2013) · cites this paper as [95]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Likewise, GROα, a potent mitogen that is a SASP component and is induced by oncogenic RAS, promotes the senescence of normal human ovarian fibroblasts (95).”
From Aging, Cellular Senescence, and Cancer (2013) · cites this paper as [95]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Thus, oncogenes such as RAS, which are known to activate protumorigenic paracrine mechanisms during transformation [ 59 – 61 ], might also exert cell-nonautonomous protumorigenic effects through nontransformed cells during the process of inducing senescence ( Figure 7 D).”
From Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor (2008) · cites this paper as [60]
The cited source says what the claim attributes to it.
In the citing paper
“the chemokine GRO1 (also known as CXCL1), which is secreted from transformed cells, can induce senescence in stromal fibroblasts 125”
From Inside and out: the activities of senescence in cancer (2014) · cites this paper as [125]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
The limited in vitro lifetime of human diploid cell strains
Hayflick, L. (1965) · Experimental Cell Research · doi:10.1016/0014-4827(65)90211-9 · Cited by 5,876
Orimo, A., Gupta, P. B., Sgroi, D. C., Arenzana-Seisdedos, F., Delaunay, T., Naeem, R., Carey, V. J., Richardson, A. L., & Weinberg, R. A. (2005) · Cell · doi:10.1016/j.cell.2005.02.034 · Cited by 3,759
Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors
Campisi, J. (2005) · Cell · doi:10.1016/j.cell.2005.02.003 · Cited by 2,379
Stromal fibroblasts in cancer initiation and progression
Bhowmick, N. A., Neilson, E. G., & Moses, H. L. (2004) · Nature · doi:10.1038/nature03096 · Cited by 2,302
Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence
Narita, M., Nuñez, S., Heard, E., Narita, M., Lin, A. W., Hearn, S. A., Spector, D. L., Hannon, G. J., & Lowe, S. W. (2003) · Cell · doi:10.1016/s0092-8674(03)00401-x · Cited by 2,278
BRAFE600-associated senescence-like cell cycle arrest of human naevi
Michaloglou, C., Vredeveld, L. C. W., Soengas, M. S., Denoyelle, C., Kuilman, T., van der Horst, C. M. A. M., Majoor, D. M., Shay, J. W., Mooi, W. J., & Peeper, D. S. (2005) · Nature · doi:10.1038/nature03890 · Cited by 2,160
Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis
Chen, Z., Trotman, L. C., Shaffer, D., Lin, H.-K., Dotan, Z. A., Niki, M., Koutcher, J. A., Scher, H. I., Ludwig, T., Gerald, W., et al. (2005) · Nature · doi:10.1038/nature03918 · Cited by 1,993
Friends or foes — bipolar effects of the tumour stroma in cancer
Mueller, M. M., & Fusenig, N. E. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1477 · Cited by 1,765
Krtolica, A., Parrinello, S., Lockett, S., Desprez, P.-Y., & Campisi, J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.211053698 · Cited by 1,730
Research works printed but not linked: 11
- AF Olumi, GD Grossfeld, SW Hayward, PR Carroll, TD Tlsty, GR Cunha Cancer Res 59, 5002–5011 (1999).
- E Balentien, BE Mufson, RL Shattuck, R Derynck, A Richmond Oncogene 6, 1115–1124 (1991).
- IM Shih, M Herlyn In Vivo 8, 113–123 (1994).
- Yang G, Rosen DG, Mercado-Uribe I, Colacino JA, Mills GB, Bast RC, Jr, Zhou C, Liu J (July 8, 2006) Carcinogenesis , 10.1093 ∕ carcin ∕ bgl115.
- Mok SC, Bell DA, Knapp RC, Fishbaugh PM, Welch WR, Muto MG, Berkowitz RS, Tsao SW (1993) Cancer Res 53:1489-1492.
- Ichikawa Y, Nishida M, Suzuki H, Yoshida S, Tsunoda H, Kubo T, Uchida K, Miwa M (1994) Cancer Res 54:33-35.
- Cuatrecasas M, Villanueva A, Matias-Guiu X, Prat J (1997) Cancer 79:1581-1586. · doi:10.1002/(sici)1097-0142(19970415)79:8<1581::aid-cncr21>3.0.co;2-t
- Cuatrecasas M, Erill N, Musulen E, Costa I, Matias-Guiu X, Prat J (1998) Cancer 82:1088-1095. · doi:10.1002/(sici)1097-0142(19980315)82:6<1088::aid-cncr12>3.0.co;2-2
- Bosman FT, de Bruine A, Flohil C, van der Wurff A, ten Kate J, Dinjens WW (1993) Int J Dev Biol 37:203-211.
- Krtolica A, Campisi J (2003) Adv Gerontol 11:109-116.
- Kacinski BM (1995) EXS 74:181-190.
Cited by
Items 101–200 of 348
Fujita, H., Ohuchida, K., Mizumoto, K., Egami, T., Miyoshi, K., Moriyama, T., Cui, L., Yu, J., Zhao, M., Manabe, T., et al. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01317.x · Cited by 78
Unexpected Pieces to the Senescence Puzzle
Cichowski, K. M., & Hahn, W. C. (2008) · Cell · doi:10.1016/j.cell.2008.05.027 · Cited by 86
“Notably, expression of oncogenic RAS was previously shown to enhance Gro-1 expression and to induce senescence of murine stromal fibroblasts, underscoring the importance of this chemokine secretory response in senescence (Yang et al., 2006).”
BackgroundKabir, T. D., Leigh, R. J., Tasena, H., Mellone, M., Coletta, R. D., Parkinson, E. K., Prime, S. S., Thomas, G. J., Paterson, I. C., Zhou, D., et al. (2016) · Aging · doi:10.18632/aging.100987 · Cited by 78
“Senescent CAF are also present in the tumour microenvironment [4] as well as in premalignant lesions [5-8] including those that precede the development of www.”
BackgroundOhtani, N. (2014) · Seminars in Immunopathology · doi:10.1007/s00281-014-0457-1 · Cited by 79
Ren, C., Cheng, X., Lu, B., & Yang, G. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2013.07.140 · Cited by 75
Self-citationMisawa, T., Tanaka, Y., Okada, R., & Takahashi, A. (2020) · Geriatrics & Gerontology International · doi:10.1111/ggi.13928 · Cited by 69
NOS2 enhances KRAS‐induced lung carcinogenesis, inflammation and microRNA‐21 expression
Okayama, H., Saito, M., Oue, N., Weiss, J. M., Stauffer, J., Takenoshita, S., Wiltrout, R. H., Hussain, S. P., & Harris, C. C. (2013) · International Journal of Cancer · doi:10.1002/ijc.27644 · Cited by 75
“KRAS induces immune responses by upregulating the production of chemokines and cytokines, which are key transcriptional targets of Ras and are required for Ras-driven tumorigenesis.(4,6,45) Consistent with previously reported lung cancer mouse models of KRAS, we observed an abundant accumulation of neutrophils and mac…”
BackgroundYung, M. M. H., Tang, H. W., Cai, P. C. H., Leung, T. H.-Y., Ngu, S., Chan, K. K. L., Xu, D., Yang, H., Ngan, H., & Chan, D. W. (2018) · Theranostics · doi:10.7150/thno.22536 · Cited by 77
“Moreover, GRO-α and IL-8 are detected in both the ascites and sera of ovarian cancer patients [38-42], wherein ascites intriguingly have a higher level of these chemokines than the respective serum samples from the same patients.”
BackgroundPremature aging/senescence in cancer cells facing therapy: good or bad?
Calvo, L., Ghadaouia, S., Martinez, A., & Rodier, F. (2015) · Biogerontology · doi:10.1007/s10522-015-9593-9 · Cited by 82
Wang, Z., Hou, J., Lu, L., Qi, Z., Sun, J., Gao, W., Meng, J., Wang, Y., Sun, H., Gu, H., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079117 · Cited by 72
“To detect anchorage-independent colony growth, soft agar assay was performed with cells stably expressing either shRPS7 or shGFP according to the previously published method [19,20].”
MethodSelf-citationZhao, B., Wu, B. C., Feng, N., Zhang, X., Zhang, X., Wei, Y., & Zhang, W. (2023) · Journal of Hematology & Oncology · doi:10.1186/s13045-023-01426-4 · Cited by 81
“Additionally, MMPs promote the release of many other cytokines and growth factors supporting tumorigenesis, such as vascular endothelial growth factor (VEGF), which promotes tumor-driven angiogenesis [70], and the chemokine CXCL1, which promotes tumor growth [71].”
BackgroundTherapeutic inhibition of CXCR1/2: where do we stand?
Sitaru, S., Budke, A., Bertini, R., & Sperandio, M. (2023) · Internal and Emergency Medicine · doi:10.1007/s11739-023-03309-5 · Cited by 74
Wei, L., Lee, J., Yeh, C., Yang, C.-J., Kok, S., Ko, J., Tsai, F., & Chia, J. (2018) · Oral Oncology · doi:10.1016/j.oraloncology.2018.11.002 · Cited by 70
Burton, D. G. A., Giribaldi, M. G., Muñoz, A., Halvorsen, K. T., Patel, A., Jordà, M., Perez‐Stable, C., & Rai, P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068003 · Cited by 73
“Senescent cells have been reported to behave like reactive tumor stroma in their ability to confer pro-malignant effects on neighboring cells [76–78].”
BackgroundCellular Senescence and Senotherapies in the Kidney: Current Evidence and Future Directions
Docherty, M. H., Baird, D., Hughes, J., & Ferenbach, D. A. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00755 · Cited by 69
Senescent stromal cells: roles in the tumor microenvironment
Gabai, Y., Assouline, B., & Ben‐Porath, I. (2022) · Trends in cancer · doi:10.1016/j.trecan.2022.09.002 · Cited by 68
Ji, Z., Tian, W., Gao, W., Zang, R., Wang, H., & Yang, G. S. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.684505 · Cited by 68
Self-citationCellular senescence and other age-related mechanisms in skeletal diseases
Li, K., Hu, S., & Chen, H. (2025) · Bone Research · doi:10.1038/s41413-025-00448-7 · Cited by 75
“202,203 Plasminogen activator inhibitor 1 also enhances replicative senescence in tumor cells.”
AKIP1 promotes angiogenesis and tumor growth by upregulating CXC-chemokines in cervical cancer cells
Zhang, W., Wu, Q., Wang, C., Yang, L., Liu, P., & Ma, C. (2018) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-018-3335-7 · Cited by 65
“Supporting the fact that CXCL1 and CXCL8 are potent factors with pro-angiogenic activities that are often upregulated in ovarian cancer [14, 15], our study revealed that not only the mRNA expression of CXCL1, CXCL2, and CXCL8 was upregulated in cervical cancer cells, but also the protein levels of these three chemokin…”
BackgroundTherapy-induced polyploidization and senescence: Coincidence or interconnection?
Sikora, E., Czarnecka‐Herok, J., Bojko, A., & Sunderland, P. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.11.015 · Cited by 68
Xu, J., Futakuchi, M., Iigo, M., Fukamachi, K., Alexander, D. B., Shimizu, H., Sakai, Y., Tamano, S., Furukawa, F., Uchino, T., et al. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq029 · Cited by 65
“chemokine family, has been shown to be involved in inflammatory responses, chemo attraction [43], carcinogenesis [44,45], and tumor progression [46].”
BackgroundDuckworth, C. A., Zhang, L., Carroll, S. L., Ethier, S. P., & Cheung, H. W. (2015) · Oncogene · doi:10.1038/onc.2015.472 · Cited by 67
“21,31 The diverse roles of NF-κ B signaling in ovarian cancer development and progression make it an attractive therapeutic target.”
InfluentialPacheco–Rodriguez, G., Kumaki, F., Steagall, W. K., Zhang, Y., Ikeda, Y., Lin, J., Billings, E. M., & Moss, J. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.3.1270 · Cited by 73
“Finally, growth-regulated oncogene 1 (Gro-1)/CXCL5 has been implicated in tumor progression by causing senescence of fibroblasts that could be associated with ovarian cancer (50).”
BackgroundGenetic alterations and epigenetic alterations of cancer-associated fibroblasts
Du, H., & Che, G. (2016) · Oncology Letters · doi:10.3892/ol.2016.5451 · Cited by 66
“Senescence that is activated by signals in CAFs, including growth‐regulated oncogene‐1 and the TGF‐β/connective tissue growth factor pathway, may fuel and promote the growth of cancer cells (39,40).”
BackgroundXiong, J., Dong, L., Lv, Q., Yin, Y., Zhao, J., Ke, Y., Wang, S., Zhang, W., & Wu, M. (2024) · Clinical and Translational Medicine · doi:10.1002/ctm2.1772 · Cited by 66
“115 In tumour xenografts, the expression of multiple characteristic SASP factors, including GATA4, MMP2/10, ITGA2 and GBP1, significantly increased after PRC2 inhibition, contributing to ECM remodelling and tumour regression.”
BackgroundTumor metabolism regulating chemosensitivity in ovarian cancer
Han, C. Y., Patten, D. A., Richardson, R. B., Harper, M., & Tsang, B. K. (2018) · Genes & Cancer · doi:10.18632/genesandcancer.176 · Cited by 64
“Chemokine growth-regulated oncogene (Gro)1 functions as an inducer of senescence in fibroblast, leading to malignant transformation of ovarian epithelial cells [192].”
BackgroundInflammation: A hidden path to breaking the spell of ovarian cancer
Shan, W., & Liu, J. (2009) · Cell Cycle · doi:10.4161/cc.8.19.9590 · Cited by 68
“that expression of the chemokine Gro-1/α was induced in HRAS-transformed ovarian epithelial cells and that epithelial cell-released Gro-1/α mediated the senescence of ovarian stromal fibroblasts by diffusing into the stroma and acting nonautonomously on fibroblasts.(39) Subsequently, ovarian fibroblasts rendered senes…”
ResultSelf-citationZhang, X., Ye, C., Sun, F. Z., Wei, W.-J., Hu, B., & Wang, J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0155725 · Cited by 66
“However, senescent cells also secrete molecules that can stimulate premalignant cells to proliferate and form tumors, suggesting the senescence response is antagonistically pleiotropic [28, 29].”
BackgroundCXCL1 promotes colon cancer progression through activation of NF-κB/P300 signaling pathway
Zhuo, C., Ruan, Q., Zhao, X., Shen, Y., & Lin, R. (2022) · Biology Direct · doi:10.1186/s13062-022-00348-4 · Cited by 66
“For example, several studies have found elevated levels of CXCL1 in plasma, serum, ascitic fluid, and tumor tissue of patients with ovarian cancer [13, 14].”
BackgroundExpression of cancer-associated fibroblast markers in advanced colorectal cancer
Nishishita, R., Morohashi, S., Seino, H., Wu, Y., Yoshizawa, T., Haga, T., Saito, K., Hakamada, K., Fukuda, S., & Kijima, H. (2018) · Oncology Letters · doi:10.3892/ol.2018.8097 · Cited by 59
“Recent studies have focused on the cancer‐associated fibroblasts (CAFs), a major cellular component of the cancer stroma, and have demonstrated that CAFs promote neoplastic angiogenesis and tumor growth in various tumors (1-6).”
Zhang, Q., Hou, X., Evans, B. J., VanBlaricom, J. L., Weroha, S. J., & Cliby, W. A. (2018) · Cancers · doi:10.3390/cancers10080260 · Cited by 65
“Louis, MO, USA) supplemented with 15% FBS (ThermoFisher, Waltham, MA, USA) and antibiotics [53].”
MMP1 drives tumor progression in large cell carcinoma of the lung through fibroblast senescence
Gabasa, M., Radisky, E. S., Ikemori, R., Bertolini, G., Arshakyan, M., Hockla, A., Duch, P., Rondinone, O., Llorente, A., Maqueda, M., et al. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.01.028 · Cited by 61
Hou, J., Wang, Z., Han, X., Yang, L., Yu, X., Yang, Z., Deng, Y., Meng, J., Feng, Y., Guo, X., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0122179 · Cited by 58
Self-citationThe Role of the Tumor Stroma in Ovarian Cancer
Davidson, B., Tropé, C. G., & Reich, R. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00104 · Cited by 58
“Induction of senescence in fibroblasts by GRO-α was previously reported to mediate tumor promotion in a previous study by the same group (110).”
BackgroundHuang, J., Zhang, J., Li, H., Lu, Z., Shan, W., Mercado‐Uribe, I., & Liu, J. (2013) · Europe PMC (PubMed Central) · Cited by 58
Self-citationThe emerging role of CXC chemokines in epithelial ovarian cancer
Rainczuk, A., Rao, J., Gathercole, J. L., & Stephens, A. N. (2012) · Reproduction · doi:10.1530/rep-12-0153 · Cited by 65
“CXCL1 has been shown to promote malignant transformation of epithelial cells through a complex RAS pathway-mediated transformation, which induces normal stroma to ‘re-program’ and become tumorigenic (Yang et al. 2006).”
BackgroundInfluentialSon, D., Kabir, S. M., Dong, Y.-L., Lee, E.-S., & Adunyah, S. E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051116 · Cited by 62
Anti-CXCL5 therapy ameliorates IL-17-induced arthritis by decreasing joint vascularization
Pickens, S. R., Chamberlain, N. D., Volin, M. V., Gonzalez, M. H., Pope, R. M., Mandelin, A. M., Kolls, J. K., & Shahrara, S. (2011) · Angiogenesis · doi:10.1007/s10456-011-9227-z · Cited by 54
Korbecki, J., Bosiacki, M., Barczak, K., Łagocka, R., Brodowska, A., Chlubek, D., & Baranowska‐Bosiacka, I. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087262 · Cited by 56
“The senescence of fibroblasts leads to an increase in CXCL1 expression in these cells [146,149].”
BackgroundLongacre, M. M., Snyder, N., Housman, G., Leary, M., LAPINSKA, K., Heerboth, S. A., Willbanks, A. R., & Sarkar, S. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17050759 · Cited by 53
Epithelial-Stromal Interactions in Pancreatic Cancer
Zhang, Y., Crawford, H. C., & Pasca di Magliano, M. (2019) · Annual Review of Physiology · doi:10.1146/annurev-physiol-020518-114515 · Cited by 49
Cellular senescence in cancer: molecular mechanisms and therapeutic targets
Jin, P., Duan, X., Li, L., Zhou, P., Zou, C., & Xie, K. (2024) · MedComm · doi:10.1002/mco2.542 · Cited by 57
Senescence: the good the bad and the dysfunctional
Pazolli, E., & Stewart, S. A. (2008) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2007.12.002 · Cited by 59
“Indeed, this study revealed that Ras expression leads to growth-related oncogene (GRO1) expression in ovarian epithelial cells [38].”
BackgroundSidler, C. L., Wóycicki, R. K., Li, D., Wang, B., Kovalchuk, I., & Kovalchuk, O. (2014) · Aging · doi:10.18632/aging.100678 · Cited by 56
REV3L, a Promising Target in Regulating the Chemosensitivity of Cervical Cancer Cells
Yang, L., Shi, T., Liu, F., Ren, C., Wang, Z., Li, Y.-Y., Tu, X., Yang, G. S., & Cheng, X. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120334 · Cited by 55
“Three short hairpin interfering RNA (shRNA) targeting REV3L were designed and chemically synthesized and inserted in pBABE/U6/Puro vector according to the previously reported method[32,33].”
MethodSelf-citationAutophagy protects ovarian cancer-associated fibroblasts against oxidative stress
Wang, Q., Xue, L., Zhang, X., Bu, S., Zhu, X., & Lai, D. (2016) · Cell Cycle · doi:10.1080/15384101.2016.1170269 · Cited by 56
“showed that ovarian cancer cells can transform CAFs into senescent fibroblasts in 26 of 31 ovarian carcinoma tissues.(22) Since senescent cells can arrest growth in G1 phase,(23) cell senescence may be the reason that CAF2 and CAF3 cannot be passaged more than 5 generations.”
BackgroundKim, E. K., Moon, S., Kim, D. K., Zhang, X., & Kim, J. (2018) · PLoS ONE · doi:10.1371/journal.pone.0188847 · Cited by 54
Iwasaki, K., Abarca, C., & Aguayo‐Mazzucato, C. (2023) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2022.0416 · Cited by 51
“However, sustained long-term secretion of SASP results in a cancer-promoting environment [37,38].”
BackgroundSpecific protein and miRNA patterns characterise tumour-associated fibroblasts in bladder cancer
Enkelmann, A., Heinzelmann, J., von Eggeling, F., Walter, M., Berndt, A., Wunderlich, H., & Junker, K. (2010) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-010-0932-6 · Cited by 49
Barajas-Gómez, B. A., Rosas‐Carrasco, Ó., Morales-Rosales, S. L., Pedraza-Vázquez, G., González‐Puertos, V. Y., Juárez‐Cedillo, T., García, J. A., López‐Díazguerrero, N. E., Damián‐Matsumura, P., Königsberg, M., et al. (2016) · Cytokine · doi:10.1016/j.cyto.2016.12.001 · Cited by 53
Ma, S., McGuire, M. H., Mangala, L. S., Lee, S., Stur, E., Hu, W. S., Bayraktar, E., Villar‐Prados, A., Ivan, C., Wu, S. Y., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108726 · Cited by 47
Self-citationGROα promotes invasion of colorectal cancer cells
Fukui (2010) · Oncology Reports · doi:10.3892/or_00001008 · Cited by 58
Asztalos, S., Pham, T. D., Gann, P. H., Hayes, M. K., Deaton, R., Wiley, E. L., Emmadi, R., Kajdacsy‐Balla, A., Banerji, N., McDonald, W., et al. (2015) · SpringerPlus · doi:10.1186/s40064-015-1512-7 · Cited by 52
The role of cellular senescence in aging through the prism of Koch-like criteria
Yanai, H., & Fraifeld, V. E. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2017.10.004 · Cited by 45
Harper, E. I., Sheedy, E. F., & Stack, M. S. (2018) · Cancers · doi:10.3390/cancers10070230 · Cited by 48
“Ovarian CAFs promote tumor growth by secreting cytokines and chemokines into the microenvironment [98,104], while non-recruited, presenescent fibroblasts do not enhance tumorigenesis [100].”
BackgroundWang, Q., Li, D., Zhang, W., Tang, B., Li, Q. Q., & Li, L. (2011) · The International Journal of Biological Markers · doi:10.5301/jbm.2011.8616 · Cited by 47
Profiling influences of senescent and aged fibroblasts on prostate carcinogenesis
Dean, J. P., & Nelson, P. S. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604087 · Cited by 42
Lawford‐Smith, H. (2015) · Journal of Social Ontology · doi:10.1515/jso-2015-0008 · Cited by 59
CXCR2 signaling regulates KRAS(G12D)-induced autocrine growth of pancreatic cancer
Purohit, A., Varney, M. L., Rachagani, S., Ouellette, M. M., Batra, S. K., & Singh, R. K. (2016) · Oncotarget · doi:10.18632/oncotarget.6906 · Cited by 46
“In ovarian cancer HRASV12-induced upregulation of hCXCL1 was found to promote tumor growth through the induction of senescence in the stromal fibroblasts [35].”
BackgroundTherapy-Induced Stromal Senescence Promoting Aggressiveness of Prostate and Ovarian Cancer
Pardella, E., Pranzini, E., Nesi, I., Parri, M., Spatafora, P., Torre, E., Muccilli, A., Castiglione, F., Fambrini, M., Sorbi, F., et al. (2022) · Cells · doi:10.3390/cells11244026 · Cited by 43
“In agreement with our data, it has been demonstrated that GRO-1-induced senescent fibroblasts promote the progression of ovarian epithelial cancer cells [67].”
BackgroundCharacteristics of chemokine signatures elicited by EGF and TNF in ovarian cancer cells
Son, D., Kabir, S. M., Dong, Y., Lee, E.-S., & Adunyah, S. E. (2013) · Journal of Inflammation · doi:10.1186/1476-9255-10-25 · Cited by 42
“These experimental findings are supported by clinical data showing that CXCL1 expression levels are greater in ovarian cancer than in normal ovary tissues and are also higher in sera from women with ovarian cancer [18].”
BackgroundMikuła‐Pietrasik, J., Uruski, P., Matuszkiewicz, K., Szubert, S., Moszyński, R., Szpurek, D., Sajdak, S., Tykarski, A., & Książek, K. (2016) · Cellular Oncology · doi:10.1007/s13402-016-0289-1 · Cited by 42
“who found that GRO-1-related signaling may elicit senescence in stromal fibroblasts [35].”
BackgroundCancer-associated cells release citrate to support tumour metastatic progression
Drexler, K., Schmidt, K. M., Jordan, K., Federlin, M., Milenkovic, V. M., Liebisch, G., Artati, A., Schmidl, C., Madej, M. G., Tokarz, J., et al. (2021) · Life Science Alliance · doi:10.26508/lsa.202000903 · Cited by 41
“GRO and MCP2 and 3 are known to transform stroma (Yang et al, 2006; Argyle & Kitamura, 2018; Sun et al, 2018), whereas IL-5 has been shown to modulate tumour environment (Zaynagetdinov et al, 2015).”
Mikuła‐Pietrasik, J., Sosińska, P., Janus, J., Rubiś, B., Brewińska‐Olchowik, M., Piwocka, K., & Książek, K. (2013) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2013.07.004 · Cited by 40
Izar, B., Joyce, C. E., Goff, S. L., Cho, N. L., Shah, P., Sharma, G., Li, J., Ibrahim, N., Gold, J. S., Hodi, F. S., et al. (2016) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12513 · Cited by 43
Grzincic, E. M., Yang, J. A., Drnevich, J. M., Falagan-Lotsch, P., & Murphy, C. J. (2014) · Nanoscale · doi:10.1039/c4nr05166a · Cited by 43
Pakuła, M., Mały, E., Uruski, P., Witucka, A., Bogucka, M., Jaroszewska, N., Makowska, N., Niklas, A., Moszyński, R., Sajdak, S., et al. (2020) · Cancers · doi:10.3390/cancers12020296 · Cited by 35
“Proteins recognized as mediators of paracrine senescence in pEOCs were previously found to exert a similar effect in fibroblasts (GRO-1 [46]), neuronal progenitors (GRO-1 [47]), peritoneal mesothelial cells (TGF-β1 [48]), hepatocellular cancer cells (TGF-β1 [49]), and lung adenocarcinoma cells [50].”
BackgroundLiu, J., Xu, K., Chase, M., Ji, Y., Logan, J. K., & Buchsbaum, R. J. (2012) · Journal of Cell Science · doi:10.1242/jcs.089466 · Cited by 40
“Significant work suggests that senescent fibroblasts contribute to tumor development in aging tissues (Krtolica et al., 2001; Krtolica and Campisi, 2002; Castro et al., 2003; Yang et al., 2006; Kang et al., 2008).”
BackgroundSelf-citationELR+ CXC chemokines and oncogenic Ras-mediated tumorigenesis
O’Hayer, K., Brady, D. C., & Counter, C. M. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp198 · Cited by 37
Complement Membrane Attack and Tumorigenesis
Towner, L. D., Wheat, R. A., Hughes, T. R., & Morgan, B. P. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.708446 · Cited by 36
Transcriptional Regulation of Chemokine Expression in Ovarian Cancer
Singha, B., Gatla, H. R., & Vancurova, I. (2015) · Biomolecules · doi:10.3390/biom5010223 · Cited by 35
“CXCL1 (GRO- ) contributes to ovarian cancer progression by inducing endothelial and epithelial cell proliferation and migration [25,26].”
BackgroundMikuła‐Pietrasik, J., Uruski, P., Pakuła, M., Maksin, K., Szubert, S., Woźniak, A., Naumowicz, E., Szpurek, D., Tykarski, A., & Książek, K. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.06.015 · Cited by 36
“GRO-1 [7], HGF [20], IL-1β [21], IL-6 [22], PAI-1 [23], TGF-β1 [10], and TNFα [24].”
BackgroundInfluentialDu, M., Qiu, Q., Gruslin, A., Gordon, J., He, M., Chan, C. C., Li, D., & Tsang, B. K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054572 · Cited by 35
“The high level of GRO-1 induces the senescence of fibroblasts and promotes malignant transformation of ovarian epithelial cells and OVCA cell growth [19] SB225002 [N-(2-hydroxy-4-nitrophenyl)-N9- (2bromophenyl) urea] is believed to be a potent selective nonpeptide CXCR2 antagonist by inhibiting the binding of both IL-…”
BackgroundWang, X., Chow, R., Deng, L., Anderson, D., Weidner, N., Godwin, A. K., Bewtra, C., Zlotnik, A., Bui, J. D., Varki, A. P., et al. (2011) · Glycobiology · doi:10.1093/glycob/cwr039 · Cited by 34
Stress responses in stromal cells and tumor homeostasis
Vitale, I., Manic, G., Galassi, C., & Galluzzi, L. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.04.004 · Cited by 34
Lawrenson, K., Grün, B., Lee, N., Mhawech-Fauceglia, P. Y., Kan, J., Swenson, S. D., Lin, Y. G., Pejovic, T. B., Millstein, J., & Gayther, S. A. (2014) · International Journal of Cancer · doi:10.1002/ijc.29092 · Cited by 34
Apoptosis or senescence? Which exit route do epithelial cells and fibroblasts preferentially follow?
Georgakopoulou, E. A., Evangelou, K., Havaki, S., Townsend, P. A., Kanavaros, P., & Gorgoulis, V. G. (2016) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2016.03.010 · Cited by 34
Hong, S., Zhang, M.-X., Zhang, M., Yu, Y., Chen, J., Zhang, X., & Xu, C. (2018) · Drug Delivery · doi:10.1080/10717544.2018.1440667 · Cited by 32
“…prepared an FSH peptide-conjugated PEG-PEI copolymer with an increased amount of PEG grafting and encapsulated shRNA to silence the target gene, growth-regulated oncogene a (gro-a), which promotes malignant transformation, tumor growth, and metastatic spread (Yang et al., 2006; Wang et al., 2017).”
BackgroundMethodNg, C.-T., Yung, L. L., Swa, H. L. F., Poh, R. W.-Y., Gunaratne, J., & Bay, B. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.10.063 · Cited by 31
Ullah, A., Chen, Y., Singla, R. K., Cao, D., & Shen, B. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107213 · Cited by 32
Lian, S., Zhai, X., Wang, X., Zhu, H., Zhang, S., Wang, W., Wang, Z., & Huang, J. (2016) · Medicine · doi:10.1097/md.0000000000004328 · Cited by 31
Metabolic dysfunction and inflammatory disease: the role of stromal fibroblasts
Farah, H., Young, S. P., Mauro, C., & Jones, S. W. (2020) · FEBS Journal · doi:10.1111/febs.15644 · Cited by 35
Higashiguchi, M., Murakami, H., Hirofumi, H., Kobayashi, S., Takahama, S., Iwagami, Y., Yamada, D., Tomimaru, Y., Noda, T., Gotoh, K., et al. (2023) · Oncology Reports · doi:10.3892/or.2023.8535 · Cited by 30
“Yang et al (36) indicated the RAS‐activated Gro‐1 strongly induces senescence of stromal fibroblasts and those senescent fibroblasts enhance the cancer cell proliferation in ovarian cancer.”
BackgroundPark, J.-H., Rasch, M. G., Qiu, J., Lund, I. K., & Egeblad, M. (2015) · Neoplasia · doi:10.1016/j.neo.2015.04.003 · Cited by 29
“Increased expression of the NF-κB–regulated CXCL9 and CXCL10 chemokines has been reported in the thymuses of p53-deficient mice compared to their wild-type littermates [54].”
BackgroundInfluentialThe Intricate Interplay between Mechanisms Underlying Aging and Cancer
Piano, A., & Titorenko, V. I. (2014) · Aging and Disease · doi:10.14336/ad.2014.0209 · Cited by 31
“[224] Yang G, Rosen DG, Zhang Z, Bast RC Jr, Mills GB, Colacino JA, Mercado-Uribe I, Liu J (2006).”
BackgroundGuo, Y., Zhang, X., Zeng, W., Zhang, J., Cai, L., Wu, Z., Su, J., Xiao, Y., Liu, N., Tang, L. Y., et al. (2020) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2020.03.950 · Cited by 30
“Recent studies have highlighted the significance of CAFs in cancer development, especially in epithelialderived cancers such as breast, gastric, lung, ovarian, and prostate carcinoma (Olumi et al., 1999; Orimo et al., 2005; Vicent et al., 2012; Yang et al., 2006).”
BackgroundLysine demethylase 2A expression in cancer-associated fibroblasts promotes breast tumour growth
Chen, J., Li, C., Lai, Y.-S., & Hung, W. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-01112-z · Cited by 28
Senescent Stromal Cells in the Tumor Microenvironment: Victims or Accomplices?
Ye, M., Huang, X., Wu, Q., & Liu, F. (2023) · Cancers · doi:10.3390/cancers15071927 · Cited by 30
“A study confirmed that the expression of the chemokine growth-regulated oncogene 1 (GRO-1, also known as TRIT1) was significantly elevated in ovarian cancer, and the overexpression was shown to be triggered by RAS signaling, resulting in inducing stromal fibroblast senescence, implicating the possibility of tumor-cell…”
BackgroundWu, Z., Neufeld, H., Torlakovic, E., & Xiao, W. (2018) · Oncotarget · doi:10.18632/oncotarget.24640 · Cited by 27
“CXCL1 is upregulated in various tumors, such as breast cancer [37, 47], ovarian cancer [48], prostate cancer [49, 50], gastric cancer [51] and bladder cancer [52, 53].”
BackgroundThe inflammatory network: bridging senescent stroma and epithelial tumorigenesis
Shan, W., Yang, G. S., & Liu, J. (2009) · Frontiers in bioscience · doi:10.2741/3511 · Cited by 34
“Results from our laboratory showed that oncogenic RAS-induced chemokine growth-regulated oncogene (Gro-1/Gro-α)̣ was adequate in rendering ovarian stromal fibroblasts senescent (9), suggesting that chemokines downstream in the RAS pathway may participate in the senescence program of neighboring fibroblasts in a paracr…”
BackgroundResultInfluentialCXC Chemokine Signaling in Progression of Epithelial Ovarian Cancer: Theranostic Perspectives
Huang, X., Hao, J., Tan, Y. Q., Zhu, T., Pandey, V., & Lobie, P. E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052642 · Cited by 29
Xiang, Z., JIANG, D.-P., Xia, G., WEI, Z.-W., CHEN, W., He, Y., & ZHANG, C.-H. (2015) · Oncology Letters · doi:10.3892/ol.2015.3614 · Cited by 26
“CXCL1-mediated melanocyte transformation is involved in the induction of Ras expression, and RAS-induced CXCL1 facilitates the transformation of human ovarian epithelial cell (4,18).”
Mikuła‐Pietrasik, J., Uruski, P., Aniukiewicz, K., Sosińska, P., Krasiński, Z., Tykarski, A., & Książek, K. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/2069290 · Cited by 28
“To this end we selected, based on literature data, four agents (TGF-β1, GRO-1, TNFα, and IL-6) known to affect cell proliferation [12], senescence [11, 13], and oxidative stress [14, 15].”
MethodGRO‐α: A Potential Marker for Cancer and Aging Silenced by RNA Interference
Fimmel, S., Devermann, L., Herrmann, A., & Zouboulis, C. C. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1404.016 · Cited by 29
CXC chemokine ligand 1 mediates adiponectin-induced angiogenesis in ovarian cancer
Ouh, Y., Cho, H., Lee, J. K., Choi, S. H., Choi, H. J., & Hong, J. H. (2019) · Tumor Biology · doi:10.1177/1010428319842699 · Cited by 26
Oncogene-Induced Senescence and its Role in Tumor Suppression
Reddy, J. P., & Li, Y. (2011) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-011-9221-5 · Cited by 29
WI-38 senescence is associated with global and site-specific hypomethylation
Sidler, C. L., Wóycicki, R. K., Kovalchuk, I., & Kovalchuk, O. (2014) · Aging · doi:10.18632/aging.100679 · Cited by 25
“On the other hand, while the pro-inflammatory microenvironment of senescent cells can contribute to the development and progression of inflammatory diseases and cancer [9, 10], the failure of senescence mechanisms can also result in malignant transformation and cancer progression [11].”
BackgroundChemokine growth‐regulated oncogene 1 as a putative biomarker for gastric cancer progression
Jung, J., Noh, S., Jeung, H., Jung, M., Kim, T. S., Noh, S. H., Roh, J. K., Chung, H. C., & Rha, S. Y. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2010.01666.x · Cited by 25
The impact of cellular senescence in cancer therapy: is it true or not?
Zhang, Y., & Yang, J. (2011) · Acta Pharmacologica Sinica · doi:10.1038/aps.2011.108 · Cited by 32
Huang, S., Ren, X., Wang, L., Zhang, L., & Wu, X. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0235 · Cited by 28
“Plasmids, shRNAs, and reagents The retroviral plasmid expressing a mutant KRAS (KRAS) was reported earlier (30).”
BackgroundMethod
Metadata
- Authors
- Yang, G., Rosen, D. G., Zhang, Z., Bast, R. C., Mills, G. B., Colacino, J. A., Mercado-Uribe, I., & Liu, J.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- Experimental Therapeutics, and
- Departments of *Pathology,
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2006-10-31
- Volume
- 103
- Issue
- 44
- Pages
- 16472-16477
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC1637606
- OpenAlex
- W1992742879
- Cited by
- 341
- References
- 49
- Citations by year
- 2026: 4 · 2025: 7 · 2024: 19 · 2023: 23 · 2022: 15 · 2021: 12 · 2020: 15 · 2019: 16 · 2018: 19 · 2017: 9 · 2016: 28 · 2015: 26 · 2014: 23 · 2013: 26 · 2012: 12
- FWCI
- 8.86
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Oncology › Ovarian cancer diagnosis and treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Keywords
- Ras signaling, cellular senescence, stromal fibroblasts, ovarian cancer, stromal-epithelial interactions, cancer-associated stroma, p53, tumor microenvironment, malignant transformation, tumor growth promotion, serum biomarkers, therapeutic target
- MeSH terms
- Cell Transformation, Neoplastic, Cells, Cultured, Female, Fibroblasts, Gene Expression Regulation, Humans, Ovarian Neoplasms, Signal Transduction, Biomarkers, Tumor Suppressor Protein p53, Cellular Senescence, Stromal Cells, Apoptosis, ras Proteins, Chemokines, CXC, Chemokine CXCL1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.